Fagron N.V.
OTC: ARSUF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Rafael Padilla
- Employees
- 3,828
- Headquarters
- Nazareth, Belgium
- IPO year
- 2017
- Market cap
- $1.9B
- Website
- https://www.fagron.com
Loading ARSUF…
Loading profile data…Frequently asked questions about ARSUF
What does Fagron N.V. (ARSUF) do?
Fagron N.V. is a specialized pharmaceutical compounding firm focused on delivering tailored medicinal solutions. The company caters to a diverse range of clients, including hospitals, pharmacies, clinics, and individual patients. Beyond providing direct services, Fagron N.V. actively drives innovation by developing cutting-edge concepts, deliver...
Where does ARSUF trade?
Fagron N.V. (ARSUF) trades on the Other OTC.
What sector is ARSUF in?
Fagron N.V. (ARSUF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Fagron N.V.?
Rafael Padilla is the chief executive officer of Fagron N.V. (ARSUF).
Where is Fagron N.V. headquartered?
Fagron N.V. is headquartered in Belgium.
Does ARSUF pay a dividend?
Yes — Fagron N.V. (ARSUF) paid a trailing twelve-month dividend of USD 0.46 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ARSUF go public?
Fagron N.V. (ARSUF) completed its initial public offering in 2017.